清消通益方对经皮冠状动脉介入治疗术后痰瘀互结型胸痹的临床疗效  

Clinical effect of Qingxiaotongyi decoction on chest obstruction of phlegm and blood stasis type after percutaneous coronary intervention

作　　者：金鑫[1] 王若楠 黎晓慧 马晓妍[1] JIN Xin;WANG Ruonan;LI Xiaohui;MAXiaoyan(Department of Geriatrics,Dalian Friendship Hospital,Dalian,Liaoning,116000,China)

机构地区：[1]大连市友谊医院老年病科,辽宁大连116000

出　　处：《当代医学》2021年第2期12-14,共3页Contemporary Medicine

基　　金：大连市卫生健康委员会课题(1611019)。

摘　　要：目的研究清消通益方对经皮冠状动脉介入治疗术后痰瘀互结型胸痹的临床疗效。方法选取2017年至2018年本院收治的经皮冠状动脉介入治疗术后患者100例为研究对象,中医证属痰瘀互结,根据随机原则分为两组,每组50例。实验组应用清消通益方联合常规西医治疗,对照组应用常规西医治疗。观察比较两组症状评分、不同时间段hs-CRP水平及治疗效果。结果实验组治疗后胸部刺痛、心悸气短评分均低于对照组(P<0.05);治疗后7、14、30 d,实验组hs-CRP水平均低于对照组(P<0.05);实验组治疗总有效率高于对照组(P<0.05)。结论清消通益方治疗经皮冠状动脉介入治疗术后痰瘀互结型胸痹效果显著,通过降低机体hs-CRP水平而降低患者术后炎症因子,稳定易损斑块,值得临床推广应用。Objective To study the clinical effect of Qingxiaotongyi decoction on chest obstruction of phlegm and blood stasis type after percutaneous coronary intervention.Methods Select 100 patients after percutaneous coronary intervention in our hospital from 2017 to 2018 as the research objects,they were divided into two groups according to random method,with 50 cases in each group.The experimental group was treated with Qingxiaotongyi formula and conventional western medicine,the control group was treated with conventional western medicine.The symptom score,hs-CRP level and the therapeutic effect of the two groups were compared.Results After treatment,the scores of chest tingling,palpitations and shortness of breath in the experimental group were lower than those in the control group(P<0.05).The levels of hs-CRP in the experimental group were lower than those in the control group at 7 days,14 days and 30 days after PCI(P<0.05).The total effective rate of the experimental group was higher than that of the control group(P<0.05).Conclusion Qingxiaotongyi decoction has significant effect on the treatment of chest obstruction of phlegm and blood stasis type after percutaneous coronary intervention.By reducing the level of hs-CRP in the body,the inflammatory factors after operation can be reduced,and then vulnerable plaque can be stabilized,which is worthy of clinical application.

关 键 词：清消通益方 经皮冠状动脉介入治疗 痰瘀互结型胸痹 临床疗效 

分 类 号：R541.4[医药卫生—心血管疾病]